| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 498.85B | 207.03B | 200.62B | 196.38B | 202.74B |
| Gross Profit | 206.28B | 207.03B | 200.62B | 196.38B | 202.74B |
| EBITDA | 120.09B | 122.85B | 0.00 | 114.27B | 108.80B |
| Net Income | 93.15B | 93.59B | 92.73B | 92.10B | 87.58B |
Balance Sheet | |||||
| Total Assets | 15.56T | 14.90T | 14.06T | 12.99T | 11.67T |
| Cash, Cash Equivalents and Short-Term Investments | 702.15B | 1.44T | 1.56T | 1.44T | 1.29T |
| Total Debt | 4.66T | 641.92B | 1.07T | 955.47B | 970.54B |
| Total Liabilities | 14.36T | 13.75T | 12.96T | 11.96T | 10.69T |
| Stockholders Equity | 1.19T | 1.14T | 1.09T | 1.02T | 964.65B |
Cash Flow | |||||
| Free Cash Flow | 80.60B | -99.52B | 89.73B | 336.57B | -57.72B |
| Operating Cash Flow | 120.04B | -57.35B | 137.32B | 368.22B | -34.77B |
| Investing Cash Flow | -747.26B | -98.09B | -116.62B | -284.90B | -75.55B |
| Financing Cash Flow | 593.05B | 42.52B | 4.89B | -32.98B | 1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.98T | 5.41 | 8.12% | 5.67% | -2.69% | 2.27% | |
76 Outperform | HK$2.73T | 6.66 | 9.18% | 4.81% | -2.85% | 10.49% | |
73 Outperform | HK$2.94T | 5.61 | 9.18% | 5.46% | -3.35% | 0.57% | |
70 Outperform | HK$2.40T | 5.23 | 9.77% | 5.64% | -4.21% | 1.01% | |
70 Outperform | HK$1.13T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
69 Neutral | HK$699.13B | 4.99 | 7.92% | 6.06% | -5.44% | -7.20% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |